Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 10/20 | 0.48 |
| ▸ | CTSS | P25774 | 10/20 | 0.48 |
| ▸ | CTSL | P07711 | 2/20 | 0.46 |
| ▸ | CTSB | P07858 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.43 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.43 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5702493 | 1.00 | CTSK (0.48) | CTSKCTSSCTSLCTSBCYP1A2 | |
| SCHEMBL1235161 | 0.91 | CTSK (0.49) | CTSKCTSSCTSLCTSBCYP1A2 | |
| SCHEMBL4279525 | 0.91 | CTSK (0.49) | CTSKCTSSCTSLCTSBCYP1A2 | |
| SCHEMBL1235160 | 0.91 | CTSK (0.49) | CTSKCTSSCTSLCTSBCYP1A2 | |
| SCHEMBL2860662 | 0.90 | ITGB3 (0.50) | CTSKCTSSCTSLCTSBCYP1A2 | |
| SCHEMBL13640176 | 0.90 | ITGB3 (0.50) | CTSKCTSSCTSLCTSBCYP1A2 | |
| SCHEMBL1277727 | 0.90 | ITGB3 (0.50) | CTSKCTSSCTSLCTSBCYP1A2 | |
| SCHEMBL29828361 | 0.89 | CTSK (0.43) | CTSKCTSSCTSLCTSBCYP1A2 | |
| SCHEMBL30385524 | 0.88 | CYP1A2 (0.47) | CTSKCTSSCTSLCTSBCYP1A2 | |
| SCHEMBL30589487 | 0.88 | ITGB3 (0.49) | CTSKCTSSCTSLCTSBCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118085531-A | Antibacterial injectable hydrogel | 南方医科大学南方医院 | 2024-05-28 | — | — | CN | claimed |
| CN-118021716-A | PH sensitive antibacterial hydrogel for injection | 南方医科大学珠江医院 | 2024-05-14 | — | — | CN | claimed |
| CN-118085531-A | Antibacterial injectable hydrogel | 南方医科大学南方医院 | 2024-05-28 | — | — | CN | disclosed |
| CN-118021716-A | PH sensitive antibacterial hydrogel for injection | 南方医科大学珠江医院 | 2024-05-14 | — | — | CN | disclosed |
| CN-1032212-C | N-protected alpha-L-aspartyl-L-methyl phenylalaninate | MITSUI TOATSU CHEMICALS (JP) | 1996-07-03 | — | — | CN | disclosed |
| EP-0334236-B1 | Preparation of n-protected alpha-l-aspartyl-l-phenylalanine methyl ester | MITSUI TOATSU CHEMICALS (JP) | 1994-08-31 | — | — | EP | disclosed |
| US-5302743-A | Reacting N-protected L-aspartic anhydride with L-phenylalanine methyl ester salt in non-aqueous solvent | MITSUI TOATSU CHEMICALS, INC. (JP) | 1994-04-12 | — | — | US | disclosed |
| CN-1036581-A | N-is protected the preparation method of 2-L-aspartyl-L-phenylalanine methyl esters | MITSUI TOATSU CHEMICALS (JP) | 1989-10-25 | — | — | CN | disclosed |
| EP-0334236-A2 | Preparation of n-protected alpha-l-aspartyl-l-phenylalanine methyl ester | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-09-27 | — | — | EP | disclosed |